Investors and Media
     
     
Events, Presentations and Webcasts
 
  Press Releases
 
  Bionovo in the News
 
  Publications
 
  FAQ
 
  Stock Details
 
  Analyst Coverage
 
  SEC Filings
 
  SEC Filings - XBRL Content
 
  Corporate Governance
 
 

BIONOVO, INC.

$0.00 (N/A)

BNVI.PK

Events, Presentations, Webcasts

Download Bionovo's Company Overview Presentation

Download Bionovo's Company Fact Sheet


Past Events

Third Quarter 2011 Financial Results Conference Call and Webcast
November 14, 2011, 1:30 PM PST
Listen to Conference Call Online:



Bionovo President, Mary Tagliaferri, to Present Tissue Selective Estrogen Receptor Modulators for Obesity
22nd Annual Meeting of the North American Menopause Society (NAMS)
Gaylord National on the Potomac
Washington, DC
September 23, 2011
View Abstract

Rodman and Renshaw 13th Annual Healthcare Conference
The Waldorf Astoria Hotel
Metropolitan East
New York, NY
September 12, 2011 2:50 PM EST
View Webcast

Conference Call: Results of the Tolerability Trial of Menerba (MF101) for Menopausal Hot Flashes
August 30, 2011, 2:00 PM PST
Conference Call Replay:

59th ASMS Conference on Mass Spectrometry and Allied Topics
Colorado Convention Center
Denver, Colorado
June 5-9, 2011

Is Your LC separation Sufficient Enough for Botanical Extracts Quantification? --Accurate LC/LC-MS/MS Quantification of 5 Polyphenolic Isomers
View Poster

Simultaneous Quantification of 7 Bioactive Polyphenolic Compounds in Menerba by a High Throughput LC-MS/MS
View Poster

Simultaneous Quantification of 8 Bioactive Polyphenolic Compounds in EDTA Rat Plasma by a High Throughput
View Poster

International Menopause Society 13th World Congress on Menopause
June 11, 2011 2:30 PM GMT
Marriot Park Hotel
Rome, Italy
Presentation by Bionovo President and CMO, Dr. Mary Tagliaferri:
Clinically Meaningful Efficacy of a Non-Estrogen Agent, MF101, for Postmenopausal Vasomotor Symptoms
Read Presentation

Estrogen Receptor Beta Symposium (Therapeutic Potential of ER-beta as Drug Target)
May 15-17, 2011
Stockholm, Sweden
Presentation by Bionovo CEO, Isaac Cohen:
Selective Estrogen Receptor beta Agonists Mechanism of Action and Clinical Applications in Women’s Health and Cancer
Read Presentation Abstract
Read Presentation

Q1 2011 Highlights and Financial Results Conference Call and Audio Webcast
May 11, 2011, 2:00 PM PST
Conference Call Replay:

 

Bionovo Annual ShareholdersMeeting
May 10, 2011 3:00 PM PST

2010 Highlights and Year End Financial Results Conference Call and Webcast
March 15, 2011, 5:30 PM EST

Cowen and Company 31st Annual Health Care Conference
March 9, 2011, 9:30 AM EST
The Boston Marriott Copley Place
Boston, Mass

Maxim Group Growth Conference
November 18, 2010
New York, NY

Third Quarter 2010 Financial Results Conference Call and Webcast
November 11, 2010, 5:00 PM EST

Dawson and James Presentation
Boca Raton, Florida
October 1, 2010

JMP Securities Healthcare Conference
September 28, 2010, 4:00 PM EST
New York Palace Hotel
New York, NY

Bionovo Investor Meeting
September 16, 2010, 3:45 pm MST
Salt Lake City, UT

Southern California Investor Conference
August 17, 2010 11:00 AM PST
Newport Beach, CA

Second Quarter 2010 Financial Results Conference Call and Webcast
August 4, 2010, 5:00 p.m. EST

58th ASMS Conference on Mass Spectrometry
May 23-27, 2010
Salt Lake City, Utah
View Presentation

Bionovo First Quarter 2010 Financial Results Conference Call and Webcast
May 11, 2010, 5:00 p.m. EST

Bionovo 2010 Annual Meeting of Stockholders
Company Headquarters
5858 Horton Street, Suite 400
Emeryville, CA 94608
May 3, 2010, 11:00 AM PST

Download 2010 Letter to Shareholders and 10K

Bionovo Fourth Quarter 2009 Financial Results Conference Call and Webcast
March 15, 2010, 5:00 PM EST

Menerba: A True Paradigm Shift
Conference Call Conducted by Dawson James Securities
November 19, 2009 1:30 PM ET

BZL: Conquering Cancer
Conference Call Conducted by Dawson James Securities
November 13, 2009 1:30 PM ET

Bionovo Third Quarter 2009 Financial Results Conference Call and Webcast
November 5, 2009, 1:45 PM PST

North American Menopause Society (NAMS) 20th Annual Meeting
October 2, 2009, 5:00 PM - 5:15 PM
San Diego, CA
Concurrent Session #2: “Plant-derived estrogen receptor α agonists selectively reverse abdominal fat accumulation without increasing mammary gland and uterus proliferation”
View Presentation

September 29, 2009
Maxim Group Growth Conference
Grand Hyatt Hotel
New York, NY

September 12, 2009, 08:30 - 10:40 AM (Central European Time)
The 8th Annual Congress of the European Society of Gynecology

Rome, Italy
Topic: Menopause and Aging in 2009: Menerba, A Novel Selective Estrogen Receptor-Beta Agonist for Climacteric Women
Oral Presentation by Dr. Mary Tagliaferri, President and CMO, Bionovo, Inc.

Bionovo Second Quarter 2009 Financial Results Conference Call and Webcast
August 10, 2009, 5:00 PM EST

BMO Capital Markets 2009 Focus on Healthcare Conference
Millenium Broadway Hotel
New York, New York
August 5, 2009, 1:45 PM EST

Bionovo First Quarter 2009 Financial Results Conference Call and Webcast
May 7, 2009, 4:30 PM EST

AACR 100th Annual Meeting 2009
Denver, CO
April 19–20 2009
View the presentation

Wall Street Analyst Forum
University Club
New York, New York
March 25, 2009 9:50 AM EST

Bionovo, Inc. Fourth Quarter and Year-End Financial Results Conference Call and Webcast
Bionovo Headquarters
Emeryville, CA
Thursday, March 12, 2009
1:30 PM PST

7th Annual BioPartnering North America Conference
Podium Presentation by Bionovo
Vancouver, BC, Canada
February 8 - 10, 2009

National Cancer Institute Office of Cancer Complementary and Alternative Medicine (OCCAM)
Bethesda, MD
Topic:Anti-tumor Effects of BZL 101 for Patients with Advanced Breast Cancer
Presented by Drs. Mary Tagliaferri and Emma Shtivelman, Bionovo Inc.
February 4, 2009
View Webcast

San Antonio Breast Cancer Symposium
San Antonio, TX
December 10 - 14, 2008
View the poster entitled, Molecular analysis of the selective pro-apoptotic effect of BN107 on estrogen receptor negative breast cancer cells
View the poster entitled, Timosaponin A3 is a steroidal saponin from Anemarrhena asphodeloides that has a selective cytotoxic activity towards cancer cells

Piper Jaffray 20th Annual Healthcare Conference
New York, New York
December 3, 2008, 8:00 AM EST

Society for Integrative Oncology Fifth International Conference
"Integration Across the Spectrum of Cancer Care"
Bionovo's Presentation Was Presented in the Best of the SIO Session
Atlanta, GA
November 20 - 21, 2008
View Presentation

Rodman & Renshaw Annual Global Investment Conference
New York, NY
November 11, 2008, 5:45 PM EST

North American Menopause Society (NAMS) 19th Annual Meeting
September 24 - 27, 2008
Orlando
View Abstract

Merriman, Curhan, Ford & Company 5th Annual Investor Summit
San Francisco
September 15, 2008

Canaccord Adams 28th Annual Global Healthcare Conference
August 13, 2008

BMO Capital Markets Focus on Healthcare 2008 Investor Conference
August 5, 2008

American Association of Cancer Research (AACR) Centennial Conference on Translational Cancer Medicine 2008
July 2008
View Presentation

2008 Annual Shareholder's Meeting
Company Headquarters, Emeryville, CA
June 17, 2008,11:00 AM PST

Endocrine Society 90th Annual Meeting
June 2008
View Presentation

56th ASMS Conference on Mass Spectrometry
June 2008
View Presentation

44th Annual American Society of Clinical Oncology Meeting
June 2008
View Presentation

Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
April 2008
View Presentation

7th Annual Oxford International Conference on the Science of Botanicals & American Society of Pharmacognosy 4th Interim Meeting
April 2008
Identification and Description of ER-beta Selective Compounds for the Treatment of Vaginal Dryness
View Presentation